Loading stock data...

Cian Healthcare Limited

BSE: CHCL

BSE
4.12 0.07 (1.73%)

Prev Close

4.05

Open Price

3.97

Volume

50,000

Today Low / High

3.97 / 4.13

52 WK Low / High

2.97 / 4.21

Range

4 - 4

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 4.12, reflecting a change of 0.07 (1.7284%). The expected target range on the BSE is 4 - 4. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

13 Jun 3.97 3.78%
12 Jun 4.05 0.00%
11 Jun 4.13 0.00%
10 Jun 4.20 -3.57%
09 Jun 4.05 1.98%
06 Jun 4.20 -3.57%
05 Jun 4.06 1.48%
04 Jun 4.04 0.00%
03 Jun 3.94 0.76%
02 Jun 3.90 0.00%
30 May 3.84 -0.26%
29 May 3.89 0.26%
28 May 3.81 0.52%
27 May 3.75 0.27%
26 May 3.62 1.93%
23 May 3.55 1.97%
22 May 3.62 -1.93%
21 May 3.62 0.00%
20 May 3.78 -2.38%
19 May 3.89 -3.34%

Cian Healthcare Limited Graph

Cian Healthcare Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Cian Healthcare Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 4.12, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 4.12 4.16 3.75 - 4.58
4.20 3.36 - 5.04
4.24 2.97 - 5.52
Bearish Scenario 4.12 4.08 3.67 - 4.49
4.04 3.23 - 4.85
4.00 2.80 - 5.20

Overview of Cian Healthcare Limited

ISIN

INE05BN01019

Industry

Medical - Pharmaceuticals

Vol.Avg

45,566

Market Cap

102,982,696

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

N/A

DCF

0

Financial Ratios Every Investor Needs

Stock Rating Details for CHCL

Metric Value Recommendation
Overall Rating C Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 5 Strong Buy

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2024-03-31 61.70 Cr 30.75 Cr 30.95 Cr 0.5017 0.00 Cr 0.00 Cr 5.40 Cr 0.25 Cr 0.10 11.31 Cr 0.0041
2023-03-31 68.59 Cr 55.25 Cr 13.34 Cr 0.1945 0.00 Cr 5.56 Cr 7.05 Cr 2.03 Cr 0.81 14.71 Cr 0.0296
2022-03-31 77.84 Cr 71.66 Cr 6.18 Cr 0.0794 0.00 Cr 5.73 Cr 0.23 Cr -5.53 Cr -2.21 7.30 Cr -0.0711
2021-03-31 73.61 Cr 60.20 Cr 13.41 Cr 0.1821 0.00 Cr 4.59 Cr 8.44 Cr 0.05 Cr 0.02 14.30 Cr 0.0007
2020-03-31 56.92 Cr 48.22 Cr 8.70 Cr 0.1528 0.00 Cr 5.72 Cr 2.88 Cr -3.79 Cr -1.62 8.76 Cr -0.0665

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2024-03-31 1.19 Cr 161.18 Cr 103.44 Cr 57.7405 Cr 55.69 Cr 54.50 Cr 44.16 Cr 55.05 Cr 4.20 Cr 0.00 Cr 4.89 Cr 66.1116 Cr
2023-03-31 1.33 Cr 160.48 Cr 102.99 Cr 57.4864 Cr 60.81 Cr 59.49 Cr 40.47 Cr 58.98 Cr 3.75 Cr 0.00 Cr 5.89 Cr 65.2663 Cr
2022-03-31 1.34 Cr 165.94 Cr 110.48 Cr 55.4569 Cr 63.05 Cr 61.71 Cr 42.75 Cr 66.94 Cr 7.12 Cr 0.00 Cr 5.89 Cr 69.4528 Cr
2021-03-31 2.32 Cr 157.25 Cr 99.01 Cr 58.2439 Cr 70.73 Cr 68.41 Cr 34.70 Cr 69.13 Cr 2.47 Cr 0.00 Cr 5.89 Cr 57.7894 Cr
2020-03-31 3.45 Cr 156.54 Cr 98.35 Cr 58.1908 Cr 73.16 Cr 69.70 Cr 22.64 Cr 74.60 Cr 3.38 Cr 0.00 Cr 5.89 Cr 48.4812 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2024-03-31 6.5430 Cr -1.5551 Cr -5.1234 Cr 5.5645 Cr -0.1355 Cr 1.1941 Cr -0.9786 Cr 0.2543 Cr -5.1235 Cr 0.0000 Cr -4.2837 Cr
2023-03-31 -0.1929 Cr 2.4148 Cr -2.2339 Cr -1.5178 Cr -0.0119 Cr 1.3296 Cr -1.3249 Cr 2.0295 Cr 0.0000 Cr 0.0000 Cr 2.7281 Cr
2022-03-31 2.6844 Cr 1.2352 Cr -4.9028 Cr -14.6333 Cr -0.9832 Cr 1.3415 Cr -17.3177 Cr -5.5335 Cr -7.6823 Cr 0.0000 Cr -8.6466 Cr
2021-03-31 -1.2241 Cr 2.5205 Cr -2.4252 Cr -2.6953 Cr -1.1288 Cr 2.3247 Cr -1.4712 Cr 0.0531 Cr 0.0000 Cr 0.0000 Cr -11.0088 Cr
2020-03-31 -14.1431 Cr -27.6232 Cr 42.7976 Cr -33.7516 Cr 1.1227 Cr 3.4535 Cr -19.6085 Cr -3.7876 Cr 8.2004 Cr 0.0000 Cr -3.7671 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2024-09-30 18.90 Cr 20.77 Cr -1.87 Cr -0.0990 -3.86 Cr -18.25 Cr -7.30 -13.41 Cr -0.9658
2024-03-31 29.08 Cr 21.59 Cr 7.50 Cr 0.2578 3.65 Cr 1.73 Cr 0.69 6.58 Cr 0.0595
2023-09-30 32.61 Cr 28.79 Cr 3.82 Cr 0.1171 1.75 Cr -1.48 Cr -0.59 4.73 Cr -0.0453
2023-03-31 37.88 Cr 32.31 Cr 5.57 Cr 0.1470 2.77 Cr 0.48 Cr 0.20 6.02 Cr 0.0126
2022-09-30 37.88 Cr 32.31 Cr 5.57 Cr 0.1470 2.77 Cr 0.48 Cr 0.20 6.02 Cr 0.0126

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2024-09-30 1.12 Cr 0.00 Cr 1.12 Cr 18.17 Cr 28.71 Cr 56.98 Cr 51.93 Cr 144.43 Cr 104.94 Cr
2024-03-31 1.19 Cr 0.00 Cr 1.19 Cr 25.55 Cr 44.16 Cr 71.74 Cr 55.05 Cr 161.18 Cr 103.44 Cr
2023-09-30 0.86 Cr 0.00 Cr 0.86 Cr 28.27 Cr 39.10 Cr 78.74 Cr 56.26 Cr 163.12 Cr 107.11 Cr
2023-03-31 1.33 Cr 0.00 Cr 1.33 Cr 31.36 Cr 40.47 Cr 74.24 Cr 58.98 Cr 160.48 Cr 102.99 Cr
2022-09-30 1.21 Cr 0.00 Cr 1.21 Cr 31.38 Cr 39.88 Cr 97.97 Cr 60.53 Cr 183.64 Cr 127.71 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-09-30 -18.25 Cr 2.87 Cr -1.13 Cr -1.82 Cr 0.00 Cr 1.12 Cr 1.19 Cr -0.38 Cr 2.49 Cr
2024-03-31 1.73 Cr 4.49 Cr -1.75 Cr -2.41 Cr 0.33 Cr 1.19 Cr 0.86 Cr -0.46 Cr 4.03 Cr
2023-09-30 -1.48 Cr 2.05 Cr 0.19 Cr -2.71 Cr -0.47 Cr 0.86 Cr 1.33 Cr -0.52 Cr 1.53 Cr
2023-03-31 0.48 Cr -0.80 Cr 2.81 Cr -1.89 Cr 0.12 Cr 1.33 Cr 1.21 Cr -0.65 Cr -1.45 Cr
2022-09-30 0.48 Cr 0.61 Cr -0.39 Cr -0.34 Cr -0.13 Cr 1.21 Cr 1.34 Cr -0.67 Cr -0.06 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹880.60 ₹105,402,386,698.00 ₹101,527.00

Key Executives

Chairman & MD
Mr. Suraj Shriniwas Zanwar

Gender: male

Year Born: 1975

Admin Manager
Ms. Kavita Suraj Zanwar B.Com.

Gender: female

Year Born: 1979

Company Secretary & Compliance Officer
Mr. Bhushan Ramesh Kulkarni

Gender: male

Year Born:

Qa/Qc Head of Technical & Whole-Time Director
Mr. Santosh Pimparkar Shivaji

Gender: male

Year Born: 1979

Chief Financial Officer
Ms. Kalyani Vijay Chordia C.A.

Gender: female

Year Born:

Marketing Manager
Mithil Maheshkumar Jhanwar

Gender: Not Specified

Year Born: 2000

Head of Supply Chain & Operations
Mr. Damodar kumar Sharma

Gender: male

Year Born: 1970

FAQs about Cian Healthcare Limited

Who is the CEO of the company?

The CEO is Mr. Suraj Shriniwas Zanwar.

What is the current market price of the stock?

The current price is ₹4.12.

What is the 52-week price range?

The range is ₹2.97-4.21.

What is the market capitalization of the company?

The market capitalization is ₹10.30 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is -0.62.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Cian Healthcare Limited (ISIN: INE05BN01019) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹10.30 crores and an average daily volume of 45,566 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.